Pathway
|
Osteoarthritis
|
|
Skin Aging
|
|
Dopamine Receptors Signaling
|
|
Serotonin Receptors Signaling
|
|
Thrombopoietin Receptors Signaling in Platelet Maturation
|
|
Toll-like Receptors Act through MYD88-TIRAP Signaling
|
|
TLR4 Signaling in Leukocytes
|
|
Plasmin Effects in Inflammation
|
|
Platelet Activation via Adhesion Molecules
|
|
Scavenger Receptors in Platelet Activation
|
|
Bradykinin Effects in Inflammation
|
|
MC1R in anti-Inflammatory Signaling
|
|
Leukotriene Effect on Vascular Endothelial Cell Response
|
|
Leukotriene Effect on Airway Smooth Muscle Response
|
|
Basophil Activation
|
|
Mast-Cell Activation without Degranulation through TNFSF8 Signaling
|
|
Mast-Cell Activation via IgE Signaling
|
|
Mast-Cell Activation without Degranulation
|
|
Mast-Cell Activation without Degranulation through IL33/IL1RL1 Signaling
|
|
Mast-Cells De Novo Synthesized Mediators via IgE Independent Signaling
|
|
Mast-Cell Activation without Degranulation through IL1R1 and TLR Signaling
|
|
Macrophage M1 Lineage
|
|
Neutrophil Recruitment and Priming
|
|
Neutrophil Degranulation via FPR1 Signaling
|
|
Vascular Endothelial Cell Activation by Cytokines
|
|
Vascular Endothelial Cell Activation by Growth Factors
|
|
GFs/TNF -> Ion Channels
|
|
Nociception Expression Targets Signaling
|
|
EDNRA/B -> Vascular Motility
|
|
ADRA1A -> IL6 Production
|
|
ADRA1 -> Prostaglandin Generation
|
|
BDKRB1/2 -> Prostaglandin Generation
|
|
CNR1/2 -> IL1B/2/4/6/10 Production
|
|
DRD2 Expression Targets
|
|
CHRM1 -> IL2 Production
|
|
HTR1 -> IL6 Production
|
|
HTR5 -> TNF Production
|
|
HTR1 -> Membrane Transport
|
|
IL1B Expression Targets -> Nociception
|
|
Circadian Clock Genes in Suprachiasmatic Nuclei Neurons
|
|
Cardiomyocyte Dysfunction
|
|
Dendritic Cells Function in Atherosclerosis
|
|
Dilated Cardiomyopathy
|
|
Cardiomyocyte Hypertrophy
|
|
Hypertrophic Cardiomyopathy
|
|
Inflammatory Reaction in Acne Vulgaris
|
|
Keratinocyte Proliferation in Acne Vulgaris
|
|
Mast-Cells Activation in Atopic Dermatitis
|
|
IL17 Signaling in Psoriasis
|
|
Dendritic Cells Function in Psoriasis
|
|
Podocyte Dysfunction in Diabetic Nephropathy
|
|
Mesangial Cell Dysfunction in Diabetic Nephropathy
|
|
Oxidation of Fatty Acid in non-Alcoholic Fatty Liver Disease
|
|
beta-Cell Destruction through Cytokines in Diabetes Mellitus
|
|
Epithelial Cell in the Innate Immune Response in Ulcerative Colitis
|
|
Antiphospholipid Antibodies in Endothelial Cell
|
|
Osteoclast Activation in Multiple Myeloma
|
|
Antiphospholipid Antibodies and Endothelial Cell Interaction
|
|
IL33 Signaling Related Eosinophilia in Asthma
|
|
IgE Induces Airway Smooth Muscle Cell Proliferation
|
|
Basophil Activation in Asthma
|
|
Mast-Cell Activation in Asthma
|
|
Mucin Production in Goblet Airway Epithelial Cells
|
|
Airway Epithelial Cell Dysfunction
|
|
CFTR Expression in Epithelial Cells (Class I Mutations)
|
|
Osteoblast Function Decline in Gout
|
|
Osteoclast Activation in Gout
|
|
TNF and IL1B Induce Metalloproteinase Synthesis in Osteoarthritis
|
|
Apoptosis of Chondrocyte
|
|
IL1B Induced Arthralgia
|
|
Dendritic Cell Dysfunction in Psoriatic Arthritis
|
|
Synovial Fibroblast Activation in Psoriatic Arthritis
|
|
Osteoclast Activation in Rheumatoid Arthritis
|
|
Synovial Fibroblast Activation by Citokines in Rheumatoid Arthritis
|
|
Apoptosis Block in Synovial Fibroblast
|
|
Autocrine Cytokine/Chemokine Loops in Systemic Scleroderma
|
|
Skin Fibrosis
|
|
CCR5 Signaling in Macrophages
|
|
Apoptosis Block in Infected Cells
|
|
Diabetes Induced Periodontitis
|
|
IL1 Receptor Antagonist (IL1RN) Deficiency (DIRA)
|
|
IL36 Receptor Antagonist (IL1F5) Deficiency (DITRA)
|
|
Bone Loss in Osteoporosis
|
|
Hyperparathyroidism, Secondary Effect
|
|
Osteoclast Activation in Postmenopause
|
|
Glioma Invasion Signaling
|
|
Growth Factor Signaling in Neuroblastoma
|
|
Neuroblastoma
|
|
Microglia and Motor Neuron Interaction Dysregulation
|
|
Breast Cancer
|
|
Angiogenesis in Endometriosis
|
|
Subepithelial Fibroblasts in Middle Ear Cholesteatoma
|
|
HPV E5 Regulates EDNRA and EGFR Signaling Pathway in Keratinocytes
|
|
Steroids Induced Cataract
|
|
VEGFA in Neovascular Glaucoma
|
|
Neurotrophic Factor Deprivation in Retinal Ganglion Cell Death
|
|
Cytokines Trigger Otitis Media
|
|
MUC5AC Expression by NTHi and S. Pneumoniae
|
|
Immune System Role in Otitis Media
|
|
Alveolar Macrophages Dysfunction in COPD
|
|
T-Cell Cytotoxic Activation
|
|
Alveolar Epithelial Cell Dysfunction in COPD
|
|
Mucin Hyperproduction in Goblet and Mucous Cells
|
|
Plasmin Role in Glomerulonephritis
|
|
Mesangial Cell Dysfunction in Glomerulonephritis
|
|
Interstitial Fibroblasts in Pyelonephritis
|
|
ANGPT1 -> CREB/CREBBP Expression Targets
|
|
ANGPT2 -> AP-1/CREBBP/MYC Expression Targets
|
|
AREG -> NFATC Expression Target
|
|
AREG -> CREB/CREBBP Expression Targets
|
|
AREG -> AP-1 Expression Targets
|
|
Acetylcholine Expression Targets
|
|
Dopamine/Gi Expression Targets
|
|
BTC -> NFATC Expression Targets
|
|
BTC -> AP-1/ATF/CREB Expression Targets
|
|
CXCR4 -> ARRB1 Signaling
|
|
Sialophorin -> CTNNB/MYC/TP53 Signaling
|
|
CD72 -> NF-kB Expression Targets
|
|
CD8 -> NF-kB Expression Targets
|
|
CD80 -> NFATC Expression Targets
|
|
CD86 -> NFATC Expression Targets
|
|
Complement Component GPCRs Signaling
|
|
Clozapine Induced Granulocytopenia
|
|
EGF -> AP-1/ATF Expression Targets
|
|
EGF -> CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
EGF -> MEF/MYOD/NFATC Expression Targets
|
|
EGF -> TP53 Expression Targets
|
|
EGFR/ERBB3 -> MEF/MYOD/NFATC/MYOG Signaling
|
|
EGFR/ERBB2 -> TP53 Signaling
|
|
EGFR -> AP-1/ATF2 Signaling
|
|
EGFR -> AP-1/CREB/ELK/SRF/MYC Signaling
|
|
EREG -> CREB Expression Target
|
|
EREG -> AP-1/ATF Expression Targets
|
|
Erythropoietin -> AP-1/MYC/CREB Expression Targets
|
|
F2 -> AP-1/CREB/ELK/SRF/SP1 Expression Targets
|
|
PLG -> AP-1/CREB/ELK/SRF/SP1 Expression Targets
|
|
FGF9 -> AP-1/CREB/MYC Expression Targets
|
|
FGF10 -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FGF1 -> AP-1/CREB/ELK/SRF/MYC Expression Targets
|
|
FGF8 -> AP-1/CREB/MYC Expression Targets
|
|
FGF18 -> AP-1/CREB Expression Targets
|
|
FGF4 -> AP-1/MYC Expression Targets
|
|
FGF7 -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FGF2 -> AP-1/CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
FGFR -> AP-1/CREB/CREBBP/ELK/SRF/MYC Signaling
|
|
ADCYAP1 Expression Targets
|
|
Glutamate/Gq Expression Targets
|
|
VIP Expression Targets
|
|
HBEGF -> AP-1/ATF Expression Targets
|
|
HBEGF -> TP53 Expression Targets
|
|
HBEGF -> MEF/MYOD Expression Target
|
|
HBEGF -> CREB/MYC Expression Targets
|
|
HGF -> AP-1/CREB/ELK/SRF/MYC Expression Targets
|
|
HGFR -> AP-1/CREB/MYC Signaling
|
|
TGFB Signaling activation by Blocking of Tumor Suppressors
|
|
TGFB Family in Epithelial to Mesenchymal Transition in Cancer
|
|
IGF1 -> MEF/MYOD/MYOG Expression Targets
|
|
IGF2/MEF/MYOD Expression Targets
|
|
Insulin -> MEF/MYOD Expression Targets
|
|
ICAM1 -> AP-1/CREB/ELK/SRF Signaling
|
|
IGF1R -> MEF/MYOD/MYOG Signaling
|
|
FibronectinR -> NF-kB Signaling
|
|
FibronectinR -> AP-1/ELK/SRF/SREBF Signaling
|
|
Fibronectin Expression Targets
|
|
CTGF -> AP-1/CREB/MYC Expression Targets
|
|
ICAM1 Expression Targets
|
|
IL1R -> NF-kB Signaling
|
|
IL16-> ATF/CREB/CREBBP Expression Target
|
|
PAF/Gq -> AP-1/ATF1/CREB/ERK/SRF Expression Targets
|
|
Dronabinol/Anandamide Expression Targets
|
|
PAF/Gq -> NF-kB Expression Targets
|
|
S1P Expression Targets
|
|
NRG1 -> MEF/MYOD Expression Targets
|
|
NRG1 -> CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
NRG1 -> TP53 Expression Target
|
|
NRG1 -> AP-1/ATF Expression Targets
|
|
NGF -> SMAD3/NF-kB Expression Targets
|
|
NGF -> AP-1/TP53/MYC Expression Targets
|
|
NGF -> FOXO/MYCN/ELK-SRF Expression Targets
|
|
BDNF Expression Targets
|
|
NTF3 Expression Targets
|
|
NTF4 Expression Targets
|
|
NGF -> CREB/CEBPB/MEF2A Expression Targets
|
|
NOTCH -> TCF3 Signaling
|
|
NOTCH Expression Targets
|
|
PDGFB -> AP-1/CREB/MYC Expression Target
|
|
PDGFC -> CREB Expression Target
|
|
PDGFD -> AP-1 Expression Targets
|
|
PDGF -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
PDGFR -> AP-1/MYC Signaling
|
|
AVP/Gs -> CREB/ELK/SRF/AP-1/EGR Expression Targets
|
|
EDN1 Expression Targets
|
|
AVP/Gs -> MEF/MYOD/NFATC/MYOG Expression Targets
|
|
AVP/Gq -> MEF/MYOD/NFATC/MYOG Expression Targets
|
|
EDN3 Expression Targets
|
|
AVP/Gq -> CREB/ELK/SRF/AP-1/EGR Expression Targets
|
|
PDCD1 -> ATF/CREB/CREBBP Expression Targets
|
|
AngiopoietinR -> AP-1 Signaling
|
|
NTRK -> AP-1/CREB/ELK/SRF/MYC/SMAD3/TP53 Signaling
|
|
GAS6 -> AP-1/CREB Expression Targets
|
|
FIGF -> AP-1 Expression Target
|
|
KITLG -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
CSF1 -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
PGF -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FLT3LG -> AP-1/CREB/CREBBP Expression Targets
|
|
TGFBR -> AP-1 Signaling
|
|
TGFBR -> CREB/ELK-SRF Signaling
|
|
TGFBR -> ATF/GADD/MAX/TP53 Signaling
|
|
TGFBR -> MEF/MYOD/MYOG Signaling
|
|
TNF-alpha/TNFRSF1A Signaling
|
|
TGF-beta Signaling
|
|
P38 MAPK/MAPK14 Signaling
|
|
VEGF Signaling
|
|
TCR -> CREB/CREBBP/ATF Expression Targets
|
|
T-Cell Receptor -> ATF/CREB Signaling
|
|
TGFA -> TP53 Expression Targets
|
|
TGFA -> MEF/MYOD/NFATC Expression Targets
|
|
TGFA/AP-1/ATF Expression Targets
|
|
TGFA -> CREB/CREBBP/ELK-SRF/MYC Expression Targets
|
|
TGFB3-TGFBR2 Expression Targets
|
|
TGFB2-TGFBR2 Expression Targets
|
|
TGFB1-TGFBR2 Expression Targets
|
|
FASLG Expression Targets
|
|
TNF -> NF-kB Expression Targets
|
|
TNFSF10 Expression Targets
|
|
LTA Expression Targets
|
|
TNFSF14 Expression Targets
|
|
TNF -> AP-1 Expression Targets
|
|
CD72 -> AP-1 Expression Targets
|
|
CD40LG -> NF-kB/ELK/SRF -> CREB/NFATC Expression Targets
|
|
TNFSF13 Expression Targets
|
|
TNFSF13B Expression Targets
|
|
TNF -> ELK-SRF Expression Targets
|
|
TNF -> CREB Expression Targets
|
|
TNF -> TP53/ATF Expression Targets
|
|
EDA Expression Targets
|
|
EctodysplasinR -> NF-kB Signaling
|
|
TNFR -> CREB/ELK-SRF Signaling
|
|
TNFR -> AP-1/ATF/TP53 Signaling
|
|
NGFR -> AP-1/CEBPB/CREB/ELK/SRF/TP53 Signaling
|
|
TNFRSF5/6 -> RB1/E2F Signaling
|
|
NGFR -> NF-kB Signaling
|
|
TNFR -> NF-kB Signaling
|
|
NGFR -> MEF Signaling
|
|
TNFRSF6 -> DDIT3 Signaling
|
|
TNFRSF1A -> AP-1/ATF/TP53 Signaling
|
|
TNFRSF1A -> CREB/ELK-SRF Signaling
|
|
Thrombopoietin -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
TLR4 -> AP-1 Expression Targets
|
|
TLR5 Expression Targets
|
|
TLR7 Expression Targets
|
|
TLR4 -> AP-1/EGR1/HIF1A Expression Targets
|
|
TLR1 -> 2/6 Expression Targets
|
|
IL1B Expression Targets
|
|
IL1A Expression Targets
|
|
TLR9 Expression Targets
|
|
TLR -> AP-1 Signaling
|
|
ER Stress (Unfolded Protein Response)
|
|
ROS in Angiotensin Mediated Cardiovascular Remodeling and Hypertrophy
|
|
VEGFA -> ATF/CREB/ELK-SRF Expression Targets
|
|
VEGFA -> NFATC Expression Targets
|
|
VEGFC -> ATF Expression Target
|
|
VEGFA -> AP-1/CREBBP/MYC Expression Targets
|
|
VEGFR -> NFATC Signaling
|
|
VEGFR -> AP-1/CREB/MYC Signaling
|
|
VEGFR -> ATF/CREB/ELK-SRF Signaling
|
|
1_Inflammation in keratinocytes in the pathology of acne
|
|
2_Interleukin-17 and interleukin-22 signaling in psoriasis
|
|
1_Osteoclast-mediated bone resorption in postmenopausal women
|
|
3_The role of interstitial fibroblasts in pyelonephritis
|
|
3_Mesangial cell dysfunction in glomerulonephritis
|
|
3_Role of neurotrophic factor deprivation in retinal ganglion cell death
|
|
2_Pathogens stimulate mucins expression in the middle ear
|
|
3_Arterial wall inflammation and calcification in atherosclerosis
|
|
2_Cardiomyocyte hypertrophy
|
|
3_Cardiomyocyte dysfunction unrelated to cell junctions in ARVD
|
|
1_Cigarette smoke causes dysfunction and production of inflammatory mediators in alveolar epithelial cells
|
|
3_Role of alveolar macrophages in pulmonary tissue destruction in COPD
|
|
4_2_Insulin resistance: inflammation-related insulin resistance
|
|
mapk1 protein modificators
|
|
Interleukin-17 and interleukin-22 signaling in psoriasis
|